Fundraising Fox

Corvidia Therapeutics

Waltham, US · Founded 2014 · 3 known investors

Find your way into Corvidia Therapeutics

Founders & leadership

MD
MARC DE GARIDELinChief Executive Officer
RA
RAM AIYARExecutive

Board

AKAARON KANTOFF
AARON KANTOFFinBoard Member2016–2019Managing Partner at Scion Life Sciences
KH
KARIM HELMYBoard director
TR
TYRELL RIVERSBoard director
GSGRAZIANO SEGHEZZI
GRAZIANO SEGHEZZIinBoard directorManaging Partner at Sofinnova Partners
SG
SYLVIE GREGOIREBoard director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$60M disclosed across 1 round · 2018

$60MraisedMay 2018 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • AARON KANTOFFDirector
  • KARIM HELMYDirector
  • MARC DE GARIDELExecutive Officer, Director
  • SYLVIE GREGOIREDirector
  • TYRELL RIVERSDirector
  • GRAZIANO SEGHEZZIDirector
  • RAM AIYARExecutive Officer
Offering amount
$60M
Amount sold
$60M
First sale
Apr 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are Corvidia Therapeutics's investors?
Corvidia Therapeutics's investors include Andera Partners, Scion Life Sciences, Sofinnova Partners.
How much funding has Corvidia Therapeutics raised?
Corvidia Therapeutics has disclosed $60M raised across 1 round.
Where is Corvidia Therapeutics headquartered?
Corvidia Therapeutics is headquartered in Waltham, US.